These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 34364168)

  • 1. Corrigendum to "Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression" [EBioMedicine 37 (2018) 47-55].
    Sun Z; Zhou S; Tang J; Ye T; Li J; Liu D; Zhou J; Wang J; Xing HR
    EBioMedicine; 2021 Aug; 70():103508. PubMed ID: 34364168
    [No Abstract]   [Full Text] [Related]  

  • 2. Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression.
    Sun Z; Zhou S; Tang J; Ye T; Li J; Liu D; Zhou J; Wang J; Rosie Xing H
    EBioMedicine; 2018 Nov; 37():47-55. PubMed ID: 30301603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.
    Szczyrba J; Nolte E; Wach S; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA
    Mol Cancer Res; 2011 Jun; 9(6):791-800. PubMed ID: 21593139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time.
    Dhondt B; De Bleser E; Claeys T; Buelens S; Lumen N; Vandesompele J; Beckers A; Fonteyne V; Van der Eecken K; De Bruycker A; Paul J; Gramme P; Ost P
    World J Urol; 2019 Dec; 37(12):2557-2564. PubMed ID: 30578441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biology of prostate cancer metastases: does oligo differ from polymetastatic?
    Sonpavde G
    Curr Opin Urol; 2017 Nov; 27(6):542-546. PubMed ID: 28786848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer.
    Xu LM; Cheng C; Kang M; Luo J; Gong LL; Pang QS; Wang J; Yuan ZY; Zhao LJ; Wang P
    Sci Rep; 2017 Aug; 7(1):9255. PubMed ID: 28835666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: A multicenter, international study.
    Barzilai O; Versteeg AL; Sahgal A; Rhines LD; Bilsky MH; Sciubba DM; Schuster JM; Weber MH; Pal Varga P; Boriani S; Bettegowda C; Fehlings MG; Yamada Y; Clarke MJ; Arnold PM; Gokaslan ZL; Fisher CG; Laufer I; The Ao Spine Knowledge Forum Tumor
    Cancer; 2019 Mar; 125(5):770-778. PubMed ID: 30489634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-21 promotes proliferation, migration, and invasion of colorectal cancer, and tumor growth associated with down-regulation of sec23a expression.
    Li C; Zhao L; Chen Y; He T; Chen X; Mao J; Li C; Lyu J; Meng QH
    BMC Cancer; 2016 Aug; 16():605. PubMed ID: 27495250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases.
    Nicosia L; Cuccia F; Mazzola R; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Bonù M; Corradini S; Tolia M; Alongi F
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2351-2358. PubMed ID: 32356176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
    Wang Y; Lieberman R; Pan J; Zhang Q; Du M; Zhang P; Nevalainen M; Kohli M; Shenoy NK; Meng H; You M; Wang L
    Mol Cancer; 2016 Nov; 15(1):70. PubMed ID: 27832783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
    Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
    Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overlapping targets exist between the Par-4 and miR-200c axis which regulate EMT and proliferation of pancreatic cancer cells.
    Katoch A; Jamwal VL; Faheem MM; Kumar S; Senapati S; Yadav G; Gandhi SG; Goswami A
    Transl Oncol; 2021 Jan; 14(1):100879. PubMed ID: 33045679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy.
    Nicosia L; Cuccia F; Mazzola R; Ricchetti F; Figlia V; Giaj-Levra N; Rigo M; Tomasini D; Pasinetti N; Corradini S; Ruggieri R; Alongi F
    Strahlenther Onkol; 2020 Sep; 196(9):813-820. PubMed ID: 32399637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
    Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
    Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-200c Inhibits the Tumor Progression of Glioma via Targeting Moesin.
    Qin Y; Chen W; Liu B; Zhou L; Deng L; Niu W; Bao D; Cheng C; Li D; Liu S; Niu C
    Theranostics; 2017; 7(6):1663-1673. PubMed ID: 28529643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Biology of Oligometastatic Prostate Cancer: A Different Beast than Polymetastatic Prostate Cancer.
    Kucharczyk MJ; Gravis G; Niazi T
    Eur Urol Focus; 2019 Mar; 5(2):117-118. PubMed ID: 30527643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value and Clinicopathology Significance of MicroRNA-200c Expression in Cancer: A Meta-Analysis.
    Wu J; Fang Z; Xu J; Zhu W; Li Y; Yu Y
    PLoS One; 2015; 10(6):e0128642. PubMed ID: 26035744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.
    Tang H; Deng M; Tang Y; Xie X; Guo J; Kong Y; Ye F; Su Q; Xie X
    Clin Cancer Res; 2013 Oct; 19(20):5602-12. PubMed ID: 23995857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression.
    Zhou X; Wang Y; Shan B; Han J; Zhu H; Lv Y; Fan X; Sang M; Liu XD; Liu W
    Med Oncol; 2015 Jan; 32(1):428. PubMed ID: 25502084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of MicroRNA-200c on Osteogenic Differentiation and Bone Regeneration by Targeting Sox2-Mediated Wnt Signaling and Klf4.
    Akkouch A; Eliason S; Sweat ME; Romero-Bustillos M; Zhu M; Qian F; Amendt BA; Hong L
    Hum Gene Ther; 2019 Nov; 30(11):1405-1418. PubMed ID: 31288577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.